Human serum amyloid protein A determination kit with high sensitivity and wide detection range
A technology of amyloid protein and human serum, which is applied in the field of immunoassay, can solve the problems of insufficient reagent detection sensitivity, insufficient sensitivity, and insufficient linear range, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0061] A human serum amyloid A assay kit, comprising reagent 1, reagent 2 and the SAA calibrator of different concentration gradients; wherein,
[0062] Reagent 1 includes the following final concentrations of components: 20 mM HEPES buffer (pH 7.2), 0.5% (w / v) of BSA, 3% (w / v) of PEG6000, 1% (w / v) of Mw Be the dextran of 40000, the KCl of 150mM, the Tween-20 of 0.05% (w / v), the ProClin300 of 0.1% (w / v), the EDTA of 2mM;
[0063] Reagent 2 includes the components of the following final concentrations: carboxyl latex microspheres (average particle diameter is 240nm, microsphere final concentration is 0.02% (w / v)), 0.0065% (w / v ) labeled human SAA monoclonal antibody, carboxyl latex microspheres labeled only with human SAA polyclonal antibody (average particle size is 123nm, final concentration of microspheres is 0.2% (w / v)), 0.04% (w / v) Labeled human SAA polyclonal antibody, 50mM MOPS buffer (pH7.4), 100mM potassium chloride, 0.3% (w / v) gelatin, 1% (w / v) BSA, 2% (w / v) sucrose ...
Embodiment 2
[0070] A human serum amyloid A assay kit, comprising reagent 1, reagent 2 and the SAA calibrator of different concentration gradients; wherein,
[0071] Reagent 1 included the following final concentrations of components: 50 mM MOPS buffer (pH 7.4), 1.5% (w / v) of BSA, 2% (w / v) of PEG8000, 5% (w / v) of Mw 5000 polylysine, 300mM NaCl, 0.05% (w / v) Tween-80, 0.1% (w / v) ProClin300, 2mM EDTA;
[0072] Reagent 2 includes components of the following final concentrations: carboxyl latex microspheres (average particle diameter of 273 nm, final microsphere concentration of 0.01% (w / v)) labeled with human SAA monoclonal antibody, 0.005% (w / v ) labeled human SAA monoclonal antibody, carboxyl latex microspheres labeled only with human SAA polyclonal antibody (average particle size is 70nm, final concentration of microspheres is 0.3% (w / v)), 0.065% (w / v) Labeled human SAA polyclonal antibody, 50mM HEPES buffer (pH7.2), 100mM ammonium chloride, 0.2% (w / v) gelatin, 0.5% (w / v) BSA, 3% (w / v) suc...
Embodiment 3
[0079] A human serum amyloid A assay kit, comprising reagent 1, reagent 2 and SAA calibrator with different concentration gradients; wherein,
[0080] Reagent 1 includes the following final concentrations of components: 50 mM PBS buffer (pH 7.4), 2% (w / v) of BSA, 1% (w / v) of PEG20000, 2% (w / v) of Mw 10000 PVP, 100mM NH 4Cl, 0.1% (w / v) Tween-80, 0.1% (w / v) ProClin300, 10 mM EDTA;
[0081] Reagent 2 includes the components of the following final concentrations: carboxyl latex microspheres (average particle diameter is 223nm, microsphere final concentration is 0.015% (w / v)), 0.0072% (w / v ) labeled human SAA monoclonal antibody, carboxyl latex microspheres labeled only human SAA polyclonal antibody (the average particle size is 83nm, the final concentration of microspheres is 0.25% (w / v)), 0.055% (w / v) Labeled human SAA polyclonal antibody, 50mM TAPS buffer (pH8.0), 50mM magnesium chloride, 0.2% (w / v) gelatin, 0.2% (w / v) BSA, 3% (w / v) sucrose, 1 % (w / v) glucose, 0.05% (w / v) Twe...
PUM
Property | Measurement | Unit |
---|---|---|
The average particle size | aaaaa | aaaaa |
The average particle size | aaaaa | aaaaa |
The average particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com